Seelos Therapeutics Inc (SEEL)

[RVL]

Off by one year.

March 18, 2013 11:00 ET | Source: Apricus Biosciences, Inc.
SAN DIEGO, March 18, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) today announced the appointment of Richard W. Pascoe as Chief Executive Officer of the Company, effective March 18, 2013. Mr. Pascoe brings to Apricus Bio over 20 years of experience in corporate strategy as well as product development, sales and marketing in the biopharmaceutical industry, and has held positions of increasing responsibility at leading, innovative life science companies, including Somaxon Pharmaceuticals, ARIAD Pharmaceuticals and King Pharmaceuticals. In addition to his role as CEO, he has also joined the Company's Board of Directors. With Mr. Pascoe's appointment, Steve Martin, Interim Chief Executive Officer, will resume his responsibilities as Senior Vice President and Chief Financial Officer.

- See more at: http://www.globenewswire.com/news-release/2013/03/18/531438/10025467/en/Apricus-Biosciences-Appoints-Richard-W-Pascoe-as-Chief-Executive-Officer.html#sthash.Q9jDnCk3.dpuf